Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging.
暂无分享,去创建一个
R. Lauffer | R. Walovitch | R B Lauffer | D J Parmelee | H S Ouellet | R C Walovitch | D. Parmelee | H. S. Ouellet
[1] K. C. Li,et al. In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits. , 1992, Magnetic resonance imaging.
[2] G. Schuhmann-Giampieri. Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. , 1993, Investigative radiology.
[3] M. Moseley,et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.
[4] E. Holtz,et al. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. , 1993, Investigative radiology.
[5] R Weissleder,et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.
[6] M. Moseley,et al. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats. , 1986, AJR. American journal of roentgenology.
[7] F. G. Larsen,et al. Serum albumin--a non-saturable carrier. , 2009, Acta pharmacologica et toxicologica.
[8] G. Adam,et al. Dynamic contrast‐enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium‐DTPA‐polylysine, and gadolinium‐DTPA‐cascade‐polymer , 1994, Magnetic resonance in medicine.
[9] T. Desser,et al. Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agents. , 1994, Investigative radiology.
[10] D. Carter,et al. Atomic structure and chemistry of human serum albumin , 1992, Nature.